Category - Executive Moves

Executive Moves

Hepion Pharma promotes Daren Ure, Daniel Trepanier and Patrick Mayo to management team

Hepion Pharmaceuticals (NASDAQ:HEPA) promoted Daren Ure, Daniel Trepanier and Patrick Mayo to the new roles of CSO; SVP of drug development; and SVP of clinical pharmacology, respectively, to further advance the...

October 3, 2019

Executive Moves

Sangamo Therapeutics names Dr. Bettina Cockroft as SVP and CMO

Sangamo Therapeutics (NASDAQ:SGMO) appointed Dr. Bettina Cockroft as SVP and CMO to oversee clinical development activities and operations. Sangamo is using its ex vivo gene-edited cell therapies and in...

September 30, 2019

Executive Moves

electroCore names Daniel Goldberger as CEO

electroCore (NASDAQ:ECOR) has appointed Daniel Goldberger as CEO, effective Oct. 1. Mr. Goldberger has more than 35 years of experience in the biotechnology and medical technology industries; with expertise in...

September 30, 2019

Executive Moves

Catabasis Pharma names Andrew Komjathy as chief commercial officer

Catabasis Pharmaceuticals (NASDAQ:CATB) appointed Andrew Komjathy as its chief commercial officer. Catabasis’ lead program is edasalonexent for the treatment of Duchenne muscular dystrophy (DMD). The company is...

September 25, 2019

Executive Moves

BriaCell names immunology expert, Cara Haymaker, to SAB

BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) appointed immunology expert, Cara Haymaker, to its scientific advisory board, effective immediately. In addition, Dr. Bill Williams, president and CEO, has been selected to...

September 25, 2019

Executive Moves

MDBriefCase names Drs. David Strain and Mohamed Farghaly as new expert advisors

Online continuing professional development provider, MDBriefCase Group (MDBC), is collaborating with Dr. David Strain, senior clinical lecturer at the University of Exeter and Dr. Mohamed Farghaly, associate professor...

September 18, 2019

Executive Moves

Stereotaxis names Kimberly Peery as CFO

Stereotaxis (NYSE American:STXS) appointed Kimberly Peery as CFO, effective October 1, replacing Martin Stammer, who has accepted a position as CFO of a large professional services firm in the St. Louis area. He will...

September 18, 2019

Executive Moves

Salarius Pharma names Scott Jordan as CBO; Mark Rosenblum as EVP finance and interim CFO

Salarius Pharmaceuticals (NASDAQ:SLRX) has appointed Scott Jordan as chief business officer (CBO) and Mark Rosenblum as EVP finance and interim CFO. Mr. Jordan has been Salarius’ CFO since 2016. As CBO, he will lead...

September 13, 2019

Executive Moves

Adamas Pharma names Neil McFarlane as CEO

Adamas Pharmaceuticals (NASDAQ:ADMS) has appointed Neil McFarlane as CEO and a member of its board, effective Sept. 16. Gregory Went, Adamas’ founder, chairman and CEO, will transition to a strategic advisory role...

September 13, 2019

Executive Moves

Gritstone Oncology adds biotech veteran, Elaine Jones, to board

Gritstone Oncology (NASDAQ:GRTS) appointed Elaine Jones as a director, replacing Peter Svennilson, founder of the Column Group and co-lead Series A investor in Gritstone. Dr. Jones was most recently VP, worldwide...

September 12, 2019

Category - Executive Moves

Hepion Pharma promotes Daren Ure, Daniel Trepanier and Patrick Mayo to management team

Sangamo Therapeutics names Dr. Bettina Cockroft as SVP and CMO

electroCore names Daniel Goldberger as CEO

Catabasis Pharma names Andrew Komjathy as chief commercial officer

BriaCell names immunology expert, Cara Haymaker, to SAB

MDBriefCase names Drs. David Strain and Mohamed Farghaly as new expert advisors

Stereotaxis names Kimberly Peery as CFO

Salarius Pharma names Scott Jordan as CBO; Mark Rosenblum as EVP finance and interim CFO

Adamas Pharma names Neil McFarlane as CEO

Gritstone Oncology adds biotech veteran, Elaine Jones, to board

Follow Us

General

More